Dasari Nagasen is a dedicated academic with a strong research focus on inclusive and accessible healthcare technologies for individuals with disabilities. Through their work, Dasari explores the integration of assistive technologies and inclusive education strategies into broader healthcare and social systems, particularly in underserved regions. Their research contributes to the intersection of disability studies, public health, and policy reforms, with the aim of promoting equal access to resources and support for individuals with disabilities. Dasari’s contributions are recognized for addressing both the technological innovations and the social policy frameworks that drive disability inclusion. Their work on the challenges faced by marginalized communities in rural and low-income settings highlights the importance of intersectionality in modern disability research.Dr. Sai Kiran Pindiprolu is an accomplished academician and researcher in the field of Pharmaceutical Sciences, with a strong specialization in pharmacology, nanomedicine, and cancer therapeutics. He earned his Ph.D. and M.Pharm. in Pharmacology from JSS Academy of Higher Education & Research, Mysuru. He has over 8 years of teaching and research experience and is currently serving as an Assistant Professor at Aditya University. He is a SERB-TARE Fellow (2021–2024) and has successfully completed a SERB-funded research project worth ₹18.3 lakhs. He is also a recipient of ICMR Senior Research Fellowship. Dr. Pindiprolu has published 50+ research articles in reputed SCI/SCIE journals with 1000+ citations (H-index: 20) and has authored multiple book chapters with leading international publishers. He holds four granted patents in the areas of nanomedicine and targeted drug delivery. His research contributions have been recognized with awards such as Best Inventor Award (2023) and Best Research Scholar Award (2019). He serves as Associate Editor and Guest Editor for several international journals and is an active reviewer for leading publishers including Springer Nature, Elsevier, Wiley, and Taylor & Francis. His research interests focus on targeted drug delivery systems, cancer stem cells, breast cancer therapy, and nanotechnology-based therapeutics.